July 19, 2018

Global Brain has invested in Undo, offering its program execution capture and replay technology in the debugging tools space, alongside with Cambridge Innovation Capital

Global Brain has invested in Undo (CEO: Greg Law), a Cambridge based company offering its program execution capture and replay technology in the debugging tools space to help others diagnose software failures, through its GB-VI Growth Fund Investment Limited Partnership and 31VENTURES Global Innovation Fund I.

Undo’s vision is to apply its unique technology to address the emerging $1trillion software accountability problems - for instance, when OEMs/Tier1s need to investigate why a self-driving car hit a pedestrian or when a bank is asked by its regulator to explain a suspect series of trades.

Undo is setting a new standard in software debugging through its program execution capture & replay technology, allowing vendors of complex Linux applications to diagnose quickly severe software failures in test or in production and fix critical bugs that are impossible to reproduce by any other means. Also, Undo’s record, rewind and replay technology is used by application vendors who would rather diagnose and fix serious software defects before they cause havoc in production. Its products are used by many of the world’s biggest software companies including SAP, Micro Focus and Mentor Graphics.

Global Brain will leverage its resources to support Undo by assisting its penetration into the Asian market, including but not limited to building partnership/alliances with its potential clients.

About Undo

Undo is a fast-growing, venture-backed technology start-up based in Cambridge, UK, with offices in the USA. Undo’s technology allows some of the biggest software companies to improve the quality of their products and fix customer issues quickly. We help our customers focus on the things that matter by reducing the time, pain and effort involved in building the world’s most complex software.

The Global Brain mark is a registered trademark of Global Brain Corporation. Other marks and trade names are the property of their respective owners.